MedTrace Logo

Transanal Total Mesorectal Excision Versus Laparoscopic TME for Rectal Cancer

NCT02252250 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2023-11-27

No results posted yet for this study

Summary

To investigates the feasibility, practicability, safety and subjective as well as functional outcome of transanal minimal invasive surgery toal mesentery excision for rectal cancer.

Conditions

  • Rectal Neoplasms

Interventions

PROCEDURE

conventional laparoscopic total mesentery excision

conventional laparoscopic total mesentery excision

PROCEDURE

transanal hybrid-laparoscopic total mesentery excision

transanal laparoscopic total mesentery excision for rectal cancer. Mobilize the rectum from down- to-up. Then, set a single incision laparoscopic surgery (SILS) port at the right-low abdomen to resect the lymph nodes of IMA.

Sponsors & Collaborators

  • Third Military Medical University

    lead OTHER

Principal Investigators

  • Weidong Tong, Prof · Daping Hospital, Third Military Medical University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2019-10-31
Completion
2020-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02252250 on ClinicalTrials.gov